We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
+9.06%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.6B
AUM Growth
+$2.6B
(+22%)
Cap. Flow
+$859M
Cap. Flow
% of AUM
5.88%
Top 10 Holdings %
Top 10 Hldgs %
21.92%
Holding
958
New
131
Increased
364
Reduced
334
Closed
74
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$135M |
| 2 |
Royal Bank of Canada
RY
|
+$120M |
| 3 |
Agilent Technologies
A
|
+$72.5M |
| 4 |
UnitedHealth
UNH
|
+$71.5M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$64.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$90.3M |
| 2 |
Amgen
AMGN
|
+$88.7M |
| 3 |
Allstate
ALL
|
+$52.2M |
| 4 |
Union Pacific
UNP
|
+$47.1M |
| 5 |
Bio-Rad Laboratories Class A
BIO
|
+$44.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 33.42% |
| 2 | Technology | 23.2% |
| 3 | Consumer Discretionary | 9.14% |
| 4 | Financials | 8.63% |
| 5 | Communication Services | 7.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Humana
HUM
$45.8B
| $5.59M | 0.04% |
12,629
-21,192
| -63% | -$9.26M |
|
377
Exelon
EXC
$48.2B
| $5.58M | 0.04% |
176,558
+4,722
| +3% | +$152K |
|
378
SL Green Realty
SLG
$3.83B
| $5.58M | 0.04% |
+69,682
| New | +$5.29M |
|
379
Hershey
HSY
$36.6B
| $5.56M | 0.04% |
31,933
+14,533
| +84% | +$2.45M |
|
380
Peloton Interactive
PTON
$2.71B
| $5.56M | 0.04% |
44,807
+19,960
| +80% | +$2.12M |
|
381
Northern Trust
NTRS
$22.4B
| $5.53M | 0.04% |
47,821
-114,852
| -71% | -$13.2M |
|
382
Goldman Sachs
GS
$309B
| $5.52M | 0.04% |
14,535
-34,851
| -71% | -$12.5M |
|
383
BioAtla
BCAB
$5.64M
| $5.49M | 0.04% |
+2,592
| New | +$5.86M |
|
384
Expeditors International
EXPD
$22.4B
| $5.47M | 0.04% |
13,285
-47,523
| -78% | -$5.61M |
|
|
HHR
385
DELISTED
HeadHunter Group PLC American Depositary Shares
HHR
| $5.46M | 0.04% |
+128,800
| New | +$4.97M |
|
386
Cummins
CMI
$91.3B
| $5.39M | 0.04% |
22,101
+5,388
| +32% | +$1.38M |
|
|
MRSH
387
Marsh
MRSH
$87.5B
| $5.37M | 0.04% |
38,166
-18,938
| -33% | -$2.54M |
|
388
Gildan
GIL
$9.38B
| $5.34M | 0.04% |
144,574
+83,826
| +138% | +$2.93M |
|
389
Welltower
WELL
$175B
| $5.34M | 0.04% |
64,256
+19,700
| +44% | +$1.51M |
|
|
FITB
390
Fifth Third Bancorp
FITB
$51.7B
| $5.32M | 0.04% |
139,132
-51,164
| -27% | -$2.05M |
|
391
eBay
EBAY
$50.3B
| $5.3M | 0.04% |
75,483
-487,576
| -87% | -$30.6M |
|
392
Dow Inc
DOW
$20.8B
| $5.27M | 0.04% |
83,300
+12,020
| +17% | +$794K |
|
393
Ford
F
$58.5B
| $5.26M | 0.04% |
354,015
-423,800
| -54% | -$5.63M |
|
|
MBT
394
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
| $5.22M | 0.04% |
+564,000
| New | +$5.01M |
|
395
United Rentals
URI
$70.2B
| $5.18M | 0.04% |
16,237
-31,815
| -66% | -$10.3M |
|
396
Truist Financial
TFC
$63.7B
| $5.18M | 0.04% |
93,260
+7,667
| +9% | +$450K |
|
|
MOR
397
DELISTED
MorphoSys AG American Depositary Shares
MOR
| $5.17M | 0.04% |
268,835
-12,646
| -4% | -$271K |
|
398
CME Group
CME
$92.3B
| $5.16M | 0.04% |
24,278
-144
| -0.6% | -$30.4K |
|
|
MASI
399
DELISTED
Masimo
MASI
| $5.11M | 0.04% |
21,090
+2,911
| +16% | +$664K |
|
400
Sempra
SRE
$59.7B
| $5.05M | 0.03% |
76,202
+1,508
| +2% | +$103K |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q2 2021 Portfolio in Review
As of Q2 2021, Candriam SCA held 958 positions worth $14.6B, up 22% from $12B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Candriam SCA deployed $859M of net new capital in Q2 2021, opening 131 new positions and adding to 364 existing holdings. Its largest new stake was SailPoint Technologies Holdings, Inc. Common Stock: 738,233 shares worth $37.7M.
By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 34% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $90.3M trimmed.
- Candriam SCA's largest Q2 2021 buy was SailPoint Technologies Holdings, Inc. Common Stock: 738,233 shares worth $37.7M.
- Candriam SCA added most to Microsoft in Q2 2021, an estimated $135M increase.
- Candriam SCA's biggest Q2 2021 reduction was Bristol-Myers Squibb, cutting an estimated $90.3M.
- Candriam SCA fully exited Tenable Holdings in Q2 2021, selling an estimated $31.6M.
- Candriam SCA's ten largest holdings make up 22% of its $14.6B portfolio in Q2 2021.
- Candriam SCA opened 131 new positions and closed 74 in Q2 2021.
- Candriam SCA's portfolio value rose 22% quarter-over-quarter to $14.6B.
Based on Candriam SCA's 13F filing for Q2 2021, filed 20 Jul 2021.